Skip to main content
. Author manuscript; available in PMC: 2022 Jun 1.
Published in final edited form as: Adv Ther (Weinh). 2021 Apr 24;4(6):2000262. doi: 10.1002/adtp.202000262

Figure 3:

Figure 3:

Various types of nanoparticles for PDAC therapy. (A) surface decorated nanoparticles to actively enhance the tumor selectivity is shown. (B) Specific nanoparticles that actively target tumor cells via receptor recognition are shown. (C) The uptake of nanoparticles via the endocytosis process results in cancer cell eradication. (Modified from Brachi et al. “Nanomedicine for imaging and therapy of pancreatic adenocarcinoma.” Frontiers in bioengineering and biotechnology 7 (2019)